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Abstract: Objectives: We have a weak understanding of how aerobic training may influence migraine,
and the optimal parameters for exercise regimens as migraine therapy are not clear. The objectives of
this study were to assess, first, effects of two different intensities of aerobic exercise on migraine headache
indices; second, serum neuro-biomarker in women migraineurs. Methods: A total of 45 non-athlete female
migraine patients were selected by a neurologist and randomly divided into three groups: control (CON),
moderate-intensity aerobic training (MOD T), and high-intensity aerobic training (HIGH T). Before
and after the training protocol, body composition factors, migraine pain indices, VO2max, and serum
Adenylate-Cyclase Activating Polypeptide (PACAP) and Substance P (SP) were measured. Exercise
training protocol includes two different intensities of aerobic exercise: Moderate (13-15 Borg Scale, 60-
80% HRmax) and High (15-17 Borg Scale, 65-95% HRmax). Results: Moderate-intensity aerobic training
(MOD T) reduced headache intensity, frequency, and duration in women with migraine (p < 0.001, for
all). Also, high-intensity aerobic training (HIGH T) reduced headache intensity, frequency, and duration
(p < 0.001, for all). However, for headache intensity and duration, MOD T was effective rather than
HIGH T (p < 0.001; p ฀ 0.05, respectively). In addition, neither MOD T nor HIGH T could not alter
PACAP and SP contents (p = 0.712; p = 0.249, respectively). Conclusions: Our results demonstrated
that either MOD T or HIGH T could modify migraine pain indices but neither MOD T nor HIGH T
could not alter the PACAP and SP contents in women with migraine.
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Objectives: We have a weak understanding of how aerobic training may influence migraine, and 43 
the optimal parameters for exercise regimens as migraine therapy are not clear. The objectives of 44 
this study were to assess, first, effects of two different intensities of aerobic exercise on migraine 45 
headache indices; second, serum neuro-biomarker in women migraineurs.  46 
Methods: A total of 45 non-athlete female migraine patients were selected by a neurologist and 47 
randomly divided into three groups: control (CON), moderate-intensity aerobic training (MOD 48 
T), and high-intensity aerobic training (HIGH T). Before and after the training protocol, body 49 
composition factors, migraine pain indices, VO2max, and serum Adenylate-Cyclase Activating 50 
Polypeptide (PACAP) and Substance P (SP) were measured. Exercise training protocol includes 51 
two different intensities of aerobic exercise: Moderate (13-15 Borg Scale, 60% to 80% HRmax) 52 
and High (15-17 Borg Scale, 65% to 95% HRmax). 53 
Results: Moderate-intensity aerobic training (MOD T) reduced headache intensity, frequency, 54 
and duration in women with migraine (p<0.001, for all). Also, high-intensity aerobic training 55 
(HIGH T) reduced headache intensity, frequency, and duration (p<0.001, for all). However, for 56 
headache intensity and duration, MOD T was effective rather than HIGH T (p<0.001; p≤0.05, 57 
respectively).  In addition, neither MOD T nor HIGH T could not alter PACAP and SP contents 58 
(p=0.712; p=0.249, respectively).  59 
Conclusions: Our results demonstrated that either MOD T or HIGH T could modify migraine 60 
pain indices but neither MOD T nor HIGH T could not alter the PACAP and SP contents in 61 
women with migraine.  62 
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BMI: Body Mass Index  87 
CGRP: Calcitonin Gene-related Peptide 88 
CON: Control  89 
CRP: C-Reactive Protein  90 
eCB: endocannabinoid  91 
HRmax: Heart Rate Maximum 92 
HIGH T: High-intensity aerobic training  93 
IL-6: Interleukine-6  94 
NPY: Neuropeptide Y  95 
NO: Nitric Oxide 96 
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RCT: Randomized Controlled Trial 99 
SNL: Spinal Nerve Ligation  100 
SP: Substance P  101 
VAS: Visual Analog Scale   102 
Vo2max: Maximum Volume of Oxygen Consumption 103 







Migraine is a debilitating neurovascular disorder characterized by severe headache attacks often 111 
associated with autonomic and neurological symptoms (Ferrari, 1998; Goadsby, Lipton, & 112 
Ferrari, 2002). Depression, chronic fatigue, disability on work, family problems, and drug 113 
dependency are some psychosocial problems related to these chronic headaches (Gantenbein, 114 
Afra, Jenni, & Sándor, 2012). It is well established that migraine headache has a higher 115 
prevalence in females than males. Many studies with a variety of samples and methodologies 116 
revealed that females have a higher prevalence ratio in migraines than males (Benbir et al, 2012; 117 
Henry et al,1999; Kim et al, 2013; Buse et al, 2013). Also, females may report more symptoms 118 
and headache-related disability (Benbir et al, 2012; Henry et al,1999; Steiner et al, 2003).  119 
 120 
The lack of suitable therapeutic modalities in managing migraine reflects the limited 121 
understanding of the pathological mechanisms behind it. According to the neurovascular theory 122 
of migraine, several neuropeptides may play a role in trigemino-neurovascular system activation, 123 
which has been considered as one of the important migraine pathomechanism (Tajti, Szok, 124 
Majláth, Tuka, & Csáti, 2015).  Several studies in this regard have reported the role of 125 
neuropeptides, including calcitonin gene-related peptide (CGRP), Nitric Oxide (NO), 126 
Neuropeptide Y (NPY), Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP) and 127 
Substance P (SP), in migraine pathophysiology (Tajti et al., 2015). 128 
 129 
Adenylate-Cyclase Activating Polypeptide (PACAP) is a multifunctional vasodilator peptide that 130 
has recently been shown to play an important role in migraine pathogenesis, such as CGRP. A 131 
new clinical study has provided evidence of a clear association between migraine phases (ictal 132 
and interictal) and plasma PACAP alterations in migraine (Tuka et al., 2013). This study showed 133 
that the plasma levels of PACAP were increased during migraine attacks compared to their 134 
interictal levels, while interictal PACAP levels were lower in comparison to healthy subjects 135 
(Tuka et al., 2013). Also, peripheral injection of PACAP in migraineurs, induced a delayed 136 
migraine-like headache, while PACAP injection in healthy subjects led to initial headache 137 
(Schytz et al., 2009). Therefore, PACAP appears to have the ability to induce a delayed 138 
migraine-like headache, such as CGRP.  139 
 140 
SP is a member of the tachykinin-neuropeptide family (Chang, Leeman, & Niall, 1971). During 141 
activation of the trigemino-neurovascular system, SP induces vasodilatation and plasma protein 142 
extra vacation in the cerebral dura mater (Buzzi & Moskowitz, 1990; Moskowitz, 1993). In the 143 
clinical situation, the salivary SP immunoreactivity was elevated during spontaneous migraine 144 
attacks without aura when compared with the control subjects (Nicolodi & Del Bianco, 1990). 145 
Also, in chronic migraine patients, the saliva and plasma levels of SP were higher than those in 146 
healthy subjects, and associated with pain intensity (Jang, Park, Kho, Chung, & Chung, 2011). 147 
Therefore, recent evidence focuses on the possible role of PACAP and SP in migraine 148 
pathophysiology. 149 
 150 
Aerobic (endurance) exercise is considered as a therapeutic method of reducing symptoms of 151 
several chronic diseases and medical conditions (Scheef et al., 2012). As direct evidence, the 152 
therapeutic effects of endurance training on migraine have been reported in numerous studies. A 153 
large body of literature addressing exercise may be particularly helpful in reducing the 154 
frequency, duration, and intensity of migraine headaches (Darabaneanu et al., 2011; Varkey E, 155 
2009; Varkey, Cider, Carlsson, & Linde, 2011 ).  However, the number of studies describing the 156 
mechanisms of exercise beneficial effects on migraine are few and limited to CGRP, NO, Beta-157 
endorphin, and, in some cases, other neuropeptides (Maeda et al., 2001; Onuoha, Nicholls, 158 
Patterson, & Beringer, 1998). For example, it has been found that beta-endorphin levels were 159 
lower in patients with migraine in comparison to healthy controls (Misra et al., 2013) where 160 
exercise resulted in increased beta-endorphin levels and consequently resulted in lower headache 161 
days (Köseoglu et al., 2003; Amin et al., 2018). However, no studies have looked at variations in 162 
PACAP and SP in migraine patients who have exercised. Therefore, the effects of exercise 163 
training biomarkers such as PACAP and SP, involved in migraine pathophysiology are not yet 164 
clear and requires further evaluation. On the other hand, when designing an appropriate aerobic 165 
program, exercise duration and intensity are usually manipulated. Because there are different 166 
aerobic training protocols to execute, identification of effective training intensity and volume 167 
(workload) is a very important issue in exercise training prescription. 168 
 169 
Given the limitations of previous studies about headache improving mediated by exercise 170 
training in the migraine society and the unknown mechanism involved in this process are strong 171 
reasons why future investigations should be performed. Consequently, the purpose of the current 172 
study was to estimate the effects of two different aerobic protocols on headache indices and to 173 
investigate the behavior of serum levels of biological markers (PACAP and SP) playing a key 174 
role in pain mechanisms, after aerobic training protocols in women migraineurs. The research 175 
hypothesis, therefore, was that the intensity of training is a main variable to determine a positive 176 
effect of MOD and HIGH aerobic training on headache indices and to be effective to decrease 177 



















Material and Methods 197 
 198 
Research design 199 
This was a randomized controlled clinical trial (RCT) with a semi-experimental design (three 200 
groups in the form of pre-test and post-test) (RCT code: IRCT2015100910824N2) and was 201 
conducted among the migraine patient’s community in Kermanshah city, Iran. The experimental 202 
procedures and study protocols were approved by the Ethics Committee of Kermanshah 203 
University of Medical Sciences (ethical code: kums.rec.1394.15). 204 
 205 
In order to determine the number of subjects, the randomized sampling method was used. 206 
Volunteers were recruited from neurology clinics, and neurology center of Kermanshah hospital 207 
(Kermanshah, Iran). The inclusion criteria were as follows: (1) Not having a history of regular 208 
exercise in the last six months, (2) having no cardiovascular disease, hypertension, diabetes, 209 
arthritis, cancer, asthma, AIDS, meningitis and Multiple Sclerosis, (3) confirming headache by 210 
the neurologist, and (4) obtaining the entry criteria for the VO2max test (above 20 ml /kg /min). 211 
Exclusion criteria were including: (1) situations that researchers have understood during research 212 
period such as pregnancy, breastfeeding, abuse of drugs or alcohol; (2) involving in any extra 213 
exercise training programs; (3) not interested to continue or change in personal life schedule.   214 
According to the study criteria for subject selection, 45 non-athlete female migraine patients 215 
were selected by the neurologist. Prior to participation, written consent was obtained from all 216 
patients. The subjects who met the inclusion criteria were randomly assigned into three groups: 217 
control (CON) (n=15), moderate-intensity aerobic training (MOD T) (n=15), and high-intensity 218 
aerobic training (HIGH T) (n=15) (Figure 1). The initial demographic characteristics of the 219 
subjects for the different groups are shown in Table 1. Patients in Control group (CON) were 220 
instructed to keep a diary regarding exercise during the experiments period. Experimental groups 221 
included MOD T and HIGH T which MOD T group executed moderate aerobic training and 222 
HIGH T group executed high-intensity aerobic training. All three groups received their drug 223 
treatment under neurologist supervision.  224 
The main protocol of this study lasted for four months: 1 month of migraine evaluation, 2 225 
months of training, and 1 month of post evaluation. One month before and after the protocol, the 226 
migraine headache indexes (i.e. frequency, duration, and intensity of the attacks) were evaluated 227 
by daily headache record questionnaire (Darabaneanu et al., 2011; Narin, Pinar, Erbas, Oztürk, & 228 
Idiman, 2003 ). In addition, 24 h before and 48 h after the training protocol, body composition 229 
factors (height, age, weight, fat percentage) (In body; Model: Zuse 9.9, South Korea), body mass 230 
index (BMI), waist-to-hip ratio (WHR) and VO2max (Astrand Bicycle, Monark E839, Sweden) 231 
were measured. 232 
Pain evaluation questionnaire 233 
The pain was evaluated using a visual analog scale (VAS). In this scale, the amount of pain that a 234 
patient feels ranges across a continuum from none to an extreme amount of pain (the number 0 235 
without pain and the number 10 indicates exacerbation of the pain). The mean duration of 236 
headache (min per month), as well as the frequency of headache (days per month) was evaluated 237 




PACAP and SP plasma levels measurements 242 
One day before starting training protocols and 48 h after the last training sessions, blood samples 243 
were collected from an cubital vein at the same time in the morning and after a 12 h fasting state. 244 
For all groups, blood samples were collected outside a migraine attack and having taken no 245 
symptomatic medication the day before. Blood samples were immediately centrifuged at a 246 
temperature of 4 °C and 3000 rpm for 10 min. Thereafter, plasma was separated and kept at -80 247 
°C until analysis. Plasma levels of PACAP and SP were measured by commercially available 248 
enzyme-linked immunosorbent assay kits (Kazabu Co, Japan, with catalog number CSB-249 
E09348h for PACAP; R & D Co, Canada, with catalog number KGE007 for SP) according to the 250 
procedures provided by the manufacturer. 251 
 252 
Exercise Training protocols 253 
As mentioned above, in this study, we have two experimental groups. These two groups not only 254 
received their drug treatment but were also treated with aerobic training including MOD T and 255 
HIGH T. As shown in Table 2, the MOD T protocol (13-15 Borg Pressure Understanding Scale, 256 
60-80 % heart rate max, equivalent to 45% -70 % VO2max) and HIGH T protocol (15-17 Borg 257 
Pressure Understanding Scale, 65-95 % heart rate max, equivalent to 55% - 90% VO2max) were 258 
designed from a simple to heavy state. A simple or heavy state was declared by subjects 259 
according to training pressure. The training programs included eight weeks, three sessions per 260 
week, 30-60 min per session including warm up and cool down. For both training groups, every 261 
training session was divided into three parts: A. warming up (10 min), B. main training 262 
(according to weekly duration), and C. cooling down (10 min) (Table 2). 263 
 264 
Drug administration 265 
It is important to mention that during study, all patients used and monitored migraine 266 
medications according to expert neurologist. Based on initial assessment by expert neurologist, 267 
needed dose of drug (including Diclofenac, Nortriptyline and Duloxetine, Sumatriptan, Depakin, 268 
Propranolol, Dexamethazone, Venlafaxine, Gabapentin, Ergotamine, Zolpidem, Codein, 269 
Ibuprofen) was administered to all patients and dose of drug used were recorded during study.  270 
 271 
Statistical analysis 272 
Data were expressed as mean ±SD. Distribution of data was assessed for normality using the 273 
Shapiro—Wilk test. The data were normally distributed, therefore, were analyzed using 274 
parametric methods. A 2 (Time) x 3 (Group) mixed-model of Repeated measures ANOVA test, 275 
followed by paired sample t-test (for pre-post comparison in every group) and Scheffe post hoc 276 
test (for between-groups comparison) were used. The differences were accepted as significant if 277 












A 2 (Time) x 3 (Group) mixed-model ANOVA for weight data analysis revealed that the main 290 
effect for time was not significant (F (1,30) = 4.934, p = 0.081, Eta-squared = 0.098). This means 291 
weight was not different between pre and post time, for three groups. Also, no significant main 292 
effect for group was obtained (F (1,30) = 2.851, p = 0.074, Eta-squared = 0.160). Thus, there was 293 
no overall difference in the weight between the three groups. However, Time x group interaction 294 
effects was significant (F (2,30) = 10.157, p < 0.0001, Eta-squared = 0.404). A comparison of 295 
means indicated that weight was decreased after aerobic training only in the MOD T group, in 296 
comparison to other groups (Table 3). 297 
In addition, data analysis of BMI showed that the main effect for group was significant (F (2,30) 298 
= 4.802, p = 0.016, Eta-squared = 0.243). Thus, there was a significant difference between the 299 
three groups. The pairwise comparison test showed that BMI in the MOD T group was 300 
significantly higher than the HIGH T group (p<0.05). Also, no significant main effect for Time 301 
was obtained (F (1,30) = 3.317, p = 0.079, Eta-squared = 0.100). This means BMI was not 302 
different between pre and post time for the three groups. However, Time x group interaction 303 
effects was significant (F (2,30) = 10.04, p < 0.0001, Eta-squared = 0.401). A comparison of 304 
means indicated that BMI decreased after aerobic training only in the MOD T group, in 305 
comparison to other groups (Table 3). The results of repeated measures ANOVA for body fat 306 
percent revealed a significant main effect for Time (F (1,30) = 13.59, p ≤ 0.001, Eta-Squared = 307 
0.312). Pairwise comparison test showed that in MOD T and HIGH T groups post-test body fat 308 
percent was significantly lower than pre-test (p < 0.001; p ≤ 0.05, respectively). This indicating 309 
that both MOD T and HIGH T were effective in body fat percent reduction in women with 310 
migraine disorder (Table 3). In addition, the main effect for group was not significant (F (2,30) = 311 
3.290, p = 0.051, Eta-squared = 0.180). Thus, there was no overall difference between the three 312 
groups for body fat percent. However, a significant Time x Group interaction effects was also 313 
obtained, F (2,30) = 6.622, p < 0.01, Eta-squared = 0.306). A comparison of means indicated 314 
that body fat percent was decreased after aerobic training only in the MOD T group, in 315 
comparison to other groups (Table 3). 316 
For VO2max, firstly, it was compared initial VO2max of patient between three groups via 317 
statistical ANOVA test where there was not any significant difference between the three groups 318 
(p = 0.088). Results showed that there was a significant main effect for Time (F (1,30) = 35.114, 319 
p < 0.0001, Eta-Squared= 0.539). The pairwise comparison test showed a significant difference 320 
between pre-test and post-test in MOD T and HIGH T groups (p < 0.001; p ≤ 0.001, 321 
respectively). This indicating that both MOD T and HIGH T were effective in VO2max 322 
improvement in women with migraine disorder; although the main effect for group was not 323 
significant (F (2,30) = 2.658, p = 0.087, Eta-squared = 0.151). Thus, there was no overall 324 
difference between the three groups for VO2max. However, a significant Time x Group 325 
interaction effects was also obtained, F (2,30) = 17.434, p < 0.0001, Eta-squared = 0.538). A 326 
comparison of means indicated that both MOD T and HIGH T groups had a significant increase 327 
in VO2max after aerobic training rather, in comparison to the CON group, however, there was 328 
not a significant difference between MOD T and HIGH T groups (Table 3).  329 
In addition, for WHR, the main effect for group was not significant (F (2,30) = 0.628, p = 0.540, 330 
Eta-squared = 0.040). Thus, there was no overall difference between the three groups. Also, no 331 
significant main effect for Time was obtained (F (1,30) = 0.657, p = 0.424, Eta-squared = 0.021). 332 
This means WHR was not different between pre and post time, for three groups. Moreover, Time 333 
x group interaction effects was not significant (F (2,30) = 1.626, p=0.214, Eta-squared = 0.098). 334 
Therefore, WHR after the two aerobic training was not different than before aerobic training 335 
(Table 3). 336 
Migraine pain indexes 337 
A 2 (Time) x 3 (Group) mixed-model ANOVA revealed that there was a strong main effect for 338 
Time (F (1,29) = 62.83, p < 0.001, Eta-Squared = 0.684). pairwise comparison test showed that 339 
in MOD T and HIGH T groups, intensity score was significantly lower in post-test rather than 340 
pre-test (p < 0.001; p ≤ 0.001, respectively). This indicated that both MOD T and HIGH T were 341 
effective in pain intensity reduction in women with migraine disorder. In addition, the main 342 
effect for group was not significant (F (2,29) = 0.389, p = 0.681, Eta-squared = 0.026). Thus, 343 
there was no overall difference between the three groups (p = 0.681). However, a significant 344 
Time x Group interaction effects was also obtained, F (2,29) = 12.241, p < 0.001, Eta-squared = 345 
0.458). Comparison of means indicated that, in comparison to the CON group, both MOD T and 346 
HIGH T groups had lower intensity the score after aerobic training rather than before aerobic 347 
training, however intensity decrease in the MOD T group was larger than HIGH T group. This 348 
means moderate-intensity aerobic training was more effective to decrease pain intensity (Table 349 
3).  350 
In addition, for frequency, there was a strong main effect for Time (F (1,29) = 85.01, p < 0.001, 351 
Eta-Squared = 0.746). The pairwise comparison test showed that, for both MOD T and HIGH T 352 
groups, the frequency score in the post-test was significantly lower than the pre-test (p < 0.001; p 353 
≤ 0.001, respectively). This indicated that both MOD T and HIGH T were effective to pain 354 
frequency reduction in women with migraine. In addition, the main effect for group was 355 
significant (F (2,29) = 4.411, p < 0.05, Eta-squared = 0.233). The pairwise comparison test 356 
showed that the frequency score in MOD T and HIGH T groups was significantly lower than the 357 
CON group (p < 0.01; p < 0.05, respectively). Also, there was not any difference between MOD 358 
T and HIGH T groups (p = 0.462). Moreover, a significant Time x Group interaction effects was 359 
also obtained, F (2,29) = 12.241, p ≤ 0.001, Eta-squared = 0.384). Comparison of means 360 
indicated that, in comparison to the CON group, both MOD T and HIGH T groups had a lower 361 
frequency the score after aerobic training rather than before aerobic training, however, there was 362 
not a significant difference between MOD T and HIGH T groups (Table 3).  363 
In addition, for Duration, a significant strong main effect for Time was obtained (F (1,29) = 364 
54.47, p < 0.001, Eta-Squared = 0.653). The pairwise comparison test showed that, for CON, 365 
MOD T, and HIGH T groups, the Duration score in the post-test was significantly lower than the 366 
pre-test (p<0.001, for all). This means migraine duration was decreased in three groups. In 367 
addition, the main effects for Group was significant (F (2,29) = 4.872, p < 0.05, Eta-squared = 368 
0.252). The pairwise comparison test showed that Duration in the HIGH T group was 369 
significantly lower than the CON group (p < 0.05). Also, there was not any difference between 370 
MOD T and HIGH T groups (p = 0.99). Moreover, a significant Time x Group interaction effects 371 
was also obtained, F (2,29) = 3.743, p ≤ 0.05, Eta-squared = 0.205). A comparison of means 372 
indicated that both MOD T and HIGH T groups had a significant decrease in duration score after 373 
aerobic training rather than before aerobic training, in comparison to the CON group. However, 374 
the decrease in the MOD T group was larger than the HIGH T group. This means moderate-375 
intensity aerobic training was more effective to decrease pain duration (Table 3). 376 
PACAP and SP 377 
For PACAP, a 2 (Time) x 3 (Group) mixed-model ANOVA revealed that the main effect for 378 
group was not significant (F (2,30) = 1.95, p = 0.160, Eta-squared = 0.115). Thus, there was no 379 
overall difference between the three groups. Also, no significant main effect for time was 380 
obtained (F (1,30) = 1.472, p = 0.234, Eta-squared = 0.047). This means PACAP levels were not 381 
different between pre and post time, for three groups. Moreover, time x group interaction effects 382 
were not significant (F (2,30) = 0.344, p = 0.712, Eta-squared = 0.022). Therefore, PACAP after 383 
the two aerobic training was not different than before aerobic training (Table 3) (Figure 2). 384 
In addition, data analysis of SP showed that the main effect for group was not 385 
significant (F (2,30) = 0.490, p = 0.618, Eta-squared = 0.032). Thus, there was no overall 386 
difference in the SP between the three groups. Also, no significant main effect for Time was 387 
obtained (F (1,30) = 1.43, p = 0.241, Eta-squared = 0.046). This means SP levels were not 388 
different between pre and post time, for three groups. Moreover, Time x group interaction effects 389 
was not significant (F (2,30) = 1.456, p = 0.249, Eta-squared = 0.089). Therefore, SP after the 390 
two aerobic training was not different than before aerobic training, in comparison to the control 391 
group (Table 3) (Figure 2). 392 
The research hypothesis, therefore, was that aerobic training with different intensities could 393 
determine the role of volume and intensity of exercise training with a positive effect on headache 394 



















The purpose of the current study was the effects of two different intensities (MOD T and HIGH 414 
T) of aerobic training protocols on headache indexes and to investigate them on a serum levels of 415 
biological markers (PACAP and SP) in women migraineurs. It was found that, after 8 weeks of 416 
MOD T, the intensity (from 7.38 to 3.73 vas), the duration (from 8.68 to 3.6 hours per month), 417 
and the frequency (from 7.54 to 2.27 times per month) of migraine headaches decreased and 418 
after 8 weeks of HIGH T, the intensity (from 5.79 to 4.22 vas), the duration (from 7.29 to 4.04 419 
hours per month), and the frequency (from 8.08 to 3.25 times per month) of migraine headaches 420 
reduced. 421 
So far, several studies have been conducted regarding exercise training and migraine pain which 422 
their results support the positive effects of aerobic training on migraine pain indicators (intensity, 423 
duration, and frequency). For example, Kroll et al. (2018) revealed that 45 min of aerobic 424 
exercise, 3 times per week, for 3 months lead to a reduction of pain intensity, pain duration, and 425 
frequency of migraine attacks. Narin et al. (2003) reported that 8 weeks of aerobic training (3 426 
sessions per week and one hour per session) reduced the intensity of migraine headaches (from 427 
8.8 to 0.4 vas), frequency of headaches (from 4.7 to 3.6 times per month), and duration of 428 
headaches (from 37.4 to 11.4 h) in migraine patients (Narin, Pinar, Erbas, Oztürk, & Idiman, 429 
2003 ). These researchers attributed the improvement in migraine pain indices to the increase of 430 
plasma nitric oxide (Narin et al., 2003 ). Also, Darabaneanu et al. (2013) conducted a study that 431 
included an aerobic exercise protocol as running for 10 weeks. They reported a significant 432 
decline in headache intensity (from 0.7 to 0.4 vas), headache frequency (from 3.8 to 2.3 times 433 
per month), and duration of headache (from 0.9 to 0.4 h per month), and these can be related to 434 
increase in physical fitness of patients (Darabaneanu et al., 2011 ). 435 
However, a number of studies could not demonstrate the effects of aerobic training on migraine 436 
headache indices. In terms of the intensity of headache, Loket et al. (1992) and Grimm et al 437 
(1981) reported that 6 weeks of aerobic training (3 sessions per week, 50 to 85% VO2max) did 438 
not have any positive effect on migraine pain intensity (Grimm, Douglas, & Hanson, 1981; 439 
Lockett & Campbell, 1992 ). In these two studies, the period of training was 6 weeks that may be 440 
too short to produce a sufficient physiological adaptation.  In terms of headache duration, 441 
Dittrich et al. (2008) did not show the effects of aerobic training on headache duration. Their 442 
exercise training program contains 6-week aerobic training with 2 sessions per week, which 443 
included 45 min of gymnastics with music and 15 min of relaxation (Dittrich et al., 2008 ). They 444 
used a training program with two sessions per week that, according to exercise training 445 
principles, cannot induce a complete sensitivity to training. In terms of the frequency of 446 
headache attacks, it was reported that 12 weeks of aerobic cycling for three days per week and 20 447 
min, each session did not show any significant effect on the frequency of headache attacks 448 
(Norlander, Cider, Carlsson, & Linde, 2007). In this study, the time of training per session was 449 
very short (20 min) that may be insufficient to induce training effects. Therefore, according to 450 
the training protocols used in previous studies, it seems that low frequency exercise training per 451 
week, short duration exercise per session, short term period (less than 6 weeks), or low total 452 
work volume per week (time*frequency) are likely important reasons for the ineffectiveness of 453 
these training programs. However, in this study, we an used aerobic training program including 3 454 
sessions per week for 8 weeks with 30-40 min per session which thought is sufficient to induce 455 
physiological and functional improvement in patient with migraine. 456 
In this study, we tried to investigate about this question “which aerobic training intensity is more 457 
appropriate for improving migraine pain indexes?” Therefore, we used two different intensity of 458 
aerobic training (MOD T (45-70% VO2max) and HIGH T (55-90% VO2max) with different 459 
training volume. The results of this study showed that the intensity of aerobic training was not 460 
the main factor in migraine pain control. This is reason why both moderate and high intensity 461 
were able to improve the parameters of migraine pain, although the moderate-intensity was 462 
somewhat more effective. Therefore, according to the results of this study, it seems that one of 463 
the main factors for the success of aerobic programs to improve the Migraine pain indices is its 464 
frequency and weekly repetitions. In other words, aerobic training with more than 3 days per 465 
week and with moderate to high-intensity levels can be useful for improving migraine pain 466 
indicators (intensity, duration, and frequency of headache attacks). In this regard, health 467 
guidelines also have reported 150 min of average intensity aerobic training and 75 min of high-468 
intensity aerobic exercises per week with a frequency of 3 to 5 sessions as a useful aerobic 469 
training program for health and physical fitness (Kaminsky, 2014). Our results also revealed that 470 
MOD T was more effective to decrease migraine pain indexes, although we expect high intensity 471 
does it. As the intensity was higher in HIGH T and the volume was higher in MOD T, the 472 
workload was calculated via time * RPE and results showed both protocols made exertion the 473 
same workload. These results indicate that both MOD T and HIGH T could be an important 474 
alternative method in monitoring headache attacks and there is no problem when patients use 475 
HIGH T and they could save their time since the time of HIGH T is shorter than MOD T. One of 476 
the differences between MOD and HIGH T probably depends on muscle fibers recruitments with 477 
showing Slow Oxidative (So) muscle fibers more involved in MOD T and Fast Oxidative 478 
Glycolytic (FOG) muscles fibers involved in HIGH T.  479 
In addition, our results showed that both moderate and high-intensity aerobic training improve 480 
VO2max and decrease body fat percentage in women with migraine. Also, MOD T could modify 481 
weight and BMI in women migraineurs. However, WHR was not affected by neither MOD T nor 482 
HIGH T. Thus, aerobic training, especially MOD T, could improve both physical fitness and 483 
health factors in women with migraines. Exercise-induced aerobic fitness can affect the 484 
physiology of migraine in multiple ways. For example, aerobic training manage weight that 485 
result in self-esteem and self-confidence in migraine patients. The body fat percentage reduction 486 
also leads to decrease inflammatory factors (e.g., IL-6 and CRP) including in migraine 487 
pathophysiology (Irby, et al., 2016). Beyond neurophysiologic pathways, improvements in 488 
aerobic fitness and migraine likely are mediated by overlapping alter in behavioral and socio-489 
cognitive factors (e.g., self-efficacy beliefs, outcome expectancies) (Irby et al., 2016; Hindiyeh, 490 
Krusz & Cowan, 2013). However, we run correlation test between VO2max and migraine 491 
indexes in post training, but our results showed no significant correlations. 492 
 493 
There are different mechanisms contributing to the reduction of migraine pain indices after 494 
exercise training. For example, Endogenous Opioids System, endocannabinoid (eCB), CGRP, 495 
and neurotrophic brain-derived factors may play a significant role in the regulation of pain 496 
signaling, which can increase their functions following aerobic exercise training and result in 497 
pain relief (Hindiyeh, Krusz, & Cowan, 2013 ). Beta-endorphin is an endogenous opioid with 498 
analgesia effects (Guillemin et al., 1977). Its levels have been found to be lower in patients with 499 
migraine in comparison to healthy control. Also, it is lower during migraine attacks than in pain-500 
free periods (Anselmi et al., 1980). It seems that beta-endorphin inhibits the release of SP which 501 
results in a lower function of pain pathways (Brunton, 2006). However, exercise can increase 502 
beta-endorphin levels. In this regard, Köseoglu et al. (2003) studied 6 weeks of aerobic exercise 503 
(40–50 min 3 times per week at 60–80% of maximal heart rate) on female migraine without aura 504 
patients during headache-free periods. They reported that the aerobic exercise increases the beta-505 
endorphin levels which possibly lead to fewer headache days.  PACAP also has been reported to 506 
be antinociceptive in the periphery (Sandor et al., 2009, 2010). One study reported that inhibition 507 
of PACAP expression in the dorsal horn may relieve pain in patients or animals with neuropathic 508 
pain (Mabochi et al., 2004). And, Yamaoka et al. (2017) reported that exercise therapy as a force 509 
treadmill running possibly involves pain relief in spinal nerve ligation (SNL) rats by suppressing 510 
PACAP expression in the spinal cord. They concluded that altered gene expression of PACAP 511 
possibly involved in the mechanism of exercise-induced analgesia for neuropathic pain in rats.  512 
In the present study, also, the effects of different intensity of aerobic training on the biological 513 
indices involved in migraine headaches were investigated. Therefore, we selected two 514 
neuropeptides involved in the pathophysiology of migraine, PACAP, and SP, which their role has 515 
recently been reported in migraine headache. According to our review of databases, not any study 516 
has been carried out to investigate the effect of exercise training on serum levels of PACAP in 517 
migraine patients. In other words, we first reported the effect of exercise training as aerobic form 518 
on serum levels of PACAP in migraine patients. PACAP has been shown to play a role in the 519 
pathogenesis of migraine, such as the CGRP (Schytz et al., 2009; Tuka et al., 2013). However, 520 
despite our expectation, the results of the present study showed that 8 weeks of both aerobic 521 
training protocols, MOD T and HIGH T, did not affect the serum levels of PACAP in migraine 522 
patients. Previous studies have shown that PACAP alterations in migraine patients were two-523 
dimensional when compared with healthy subjects. The quantitative changes in this peptide in the 524 
plasma are related to the disease duration. PACAP-38 concentration has been shown significantly 525 
lower in the interictal plasma of the migraineurs as compared with the healthy controls and plasma 526 
and significantly higher in the ictal phase relative to the attack-free (Tuka et al., 2013). In this 527 
study, significantly lower PACAP-38-LI was determined in the interictal plasma of the 528 
migraineurs (n=80; 24.60±3.59 fmol/ml) than in that of the healthy volunteers (n=40; 26.54±4.43 529 
fmol/ml). However, the plasma samples from the patients during their migraine attacks (n=28) 530 
exhibited a significantly higher PACAP-38 concentration (27.39±4.67fmol/ml) as compared with 531 
the interictal samples (n=59; 24.91±3.73 fmol/ml) (Tuka et al., 2013).  532 
Therefore, the pattern of PACAP alteration in migraine patients is a sinusoidal and does not have 533 
a consistent level in these patients. In the present study, we used 8 weeks aerobic training 534 
protocols, which included a number of these attack periods and between attacks periods. 535 
Although, patient’s migraine state in moment of blood collection may has a critical role in 536 
plasma PACAP level, however, in our study, it was not possible to collected blood samples in 537 
same migraine phase (ictal or interictal) since time of last training session until blood collection 538 
moment must to be same for all subjects. It, therefore, is likely that, in moment of blood 539 
collection, some of subjects were in ictal phase and some other were in interictal phase. 540 
Therefore, the sinus pattern of the PACAP alteration pattern can be one of the possible reasons 541 
for the unchanging it after aerobic training protocols. It was suggested that the effect of aerobic 542 
training on serum PACAP would be investigated in separated periods of ictal and interictal. 543 
Another possibility for the unchanging PACAP serum levels following aerobic training in 544 
migraine patients is neuroprotective and neurotrophic role of PACAP. PACAP is expressed 545 
throughout the central nervous system (CNS), such as the hypothalamus, hippocampus, 546 
cerebellum, and sensory neurons (Arimura et al., 1994; Hannibal, 2002; Sundler et al., 1996 ), 547 
and this indicates its polyotropic functions in the CNS. PACAP has been shown to act as a nerve 548 
hormone, neurotransmitter, and neurotrophic agent (Gonzalez, Basille, Vaudry, Fournier, & 549 
Vaudry, 1997; Lioudyno, Skoglösa, Takei, & Lindholm, 1998; Vaudry et al., 2000 ). In the adult 550 
brain, PACAP prevents apoptotic cell death and can be a regenerative factor in various 551 
pathological conditions (Morio, Tatsuno, Hirai, Tamura, & Saito, 1996). Therefore, considering 552 
other roles and functions of PACAPs in the central nervous system, it seems that in migraines, 553 
the levels of this protein, on the one hand, are affected by migraine disease, and on the other 554 
hand, it requires different expressions for its other functions. Taking this into account, exercise 555 
training can affect PACAP roles in the nervous system. In general, it seems that the impact of 556 
aerobic training on PACAP in migraine patients will be different from that in healthy people. 557 
Therefore, in order to better determine the role of physical activity, such as aerobic training on 558 
PACAP in migraines, it is better to study the PACAP level in target tissues and local sites. 559 
For the first time, we studied the effect of aerobic training with different intensities (MOD T and 560 
HIGH T) on serum SP levels in migraine patients. Interestingly, none of the aerobic training 561 
doses, medium, and high intensity, could have any effect on serum SP levels in migraine 562 
patients. The role of SP as a vasodilator in the brain has been mentioned in previous studies and 563 
was considered as a pain modulator (Beattie, Connor, & Hagan, 1995 ). In the clinical situations, 564 
it has also been shown that, when migraine attacks were triggered, the salivary SP level was 565 
increased in migraine patients as compared with the control group (Nicolodi & Del Bianco, 566 
1990). The role of SP in migraine disease is well articulated in previous studies (Fusayasu, 567 
Kowa, Takeshima, Nakaso, & Nakashima, 2007; Jang, Park, Kho, Chung, & Chung, 2011). 568 
Nevertheless, the results of this study showed that aerobic training with moderate and high 569 
intensity did not have any significant effect on serum SP levels in migraine patients. In this 570 
regard, it expected that serum SP level would decrease after 8 weeks of aerobic training, but its 571 
serum levels did not change. The absence of change in SP after aerobic training may be 572 
attributed to other SP roles in the nervous system. Substance P has been shown to have 573 
neurotrophic effects and improve memory (Skoff, Zhao, & Adler, 2009 ). Electrophysiological 574 
studies have also shown that SP induces nigral dopaminergic neurons (Skoff et al., 2009 ). SP 575 
also increases dopamine release from dopamine terminals (Gayen, Goswami, & Mukhopadhyay, 576 
2011 ), which may be involved in maintaining the integrity of the nerve population (Marolda et 577 
al., 2012 ). It also is involved in learning and memory, mood and anxiety, stress mechanisms, 578 
and pain (Xu, Xie, Li, Zhang, & Hou, 2013). Therefore, SP has many different functions in the 579 
nervous system, which may require different doses of it. However, the mechanisms underlying 580 
SP expression and its influence on migraine pain adaptation to exercise training are not entirely 581 




In summary, the present study showed that aerobic training with moderate and high intensities 586 
could significantly reduce migraine pain indices including headache intensity, duration, and 587 
frequency of attacks in migraine women. Although, role of PACAP and SP in beneficial effects 588 
of aerobic training on migraine indices remain unclear, however, these effects of aerobic training 589 
on migraine pain indices can be attributed to various mechanisms that require further studies. In 590 
addition, our results showed that the intensity of aerobic training was not the main factor in 591 
migraine pain modification, although both aerobic training protocols could be alternative non-592 
pharmacological method to monitor the headache in women with migraine disorder.   593 
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25.16±6.08 38.41±6.20 32.44±5.74 Age (years)  
57.12±10.84 69.75±14.42 61.98±10.55 Weight (kg) 
21.00±3.1 26.93±5.65 24.10±4.42 BMI (kg/m2) 
33.90±8.83 28.69±4.48 36.89±11.23 VO2max (ml/kg/min) 
21.60±6.57 29.87±10.19 28.54±6.89 Body Fat (%) 










































































































70 70 68 68 60 50 46 45 Intensity 
(%VO2max) 
40 40 40 35 30 25 18 7 Time (min) 









































90 88 88 83 80 72 70 55 Intensity 
(%VO2max) 
30 30 30 25 20 15 10 5 Time (min) 
510 510 480 400 280 180 120 50 Work load 
(RPE*time) 
Table 3: The comparison of variables in pre and post time and between three groups (time effects 836 




































Weight (kg)                     Pre:  
















BMI (kg/m2)                     Pre  

















VO2max                            Pre: 

















Body Fat (%)                    Pre: 



































Pain intensity Pre: 

















Pain frequency Pre: 
















Pain Duration                   Pre: 




































(pg/ml)                                        Post: 
 
CON: Control; MOD T; Moderate-intensity aerobic training; HIGH T: High-intensity aerobic training 838 
* Significant pre-post different 839 
# Significant time effect 840 
$ Significant time*group interaction effect 841 




Figure2: PACAP (a) and SP (b) contents in three groups in pre and post training. CON: Control group; MOD: Moderate intense aerobic 846 
training group; HIGH: High intense aerobic training. 847 
